Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 04:02 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | AR | 65 beds | Grade C | EBITDA uplift $2.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 043028 | SEBASTIAN, AR | 65 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 65-bed suburban community hospital in SEBASTIAN, AR with $28.6M in net patient revenue and a 14.6% operating margin. The hospital serves a payer mix of 67.3% Medicare, 6.1% Medicaid, and 26.6% commercial.

Thesis: Turnaround. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 14.6% to 22.0% (+736bps).

Net Revenue HCRIS$28.6M
Current EBITDA COMPUTED$4.2M
Operating Margin COMPUTED14.6%
Occupancy HCRIS80.6%
Revenue / Bed COMPUTED$441K
Net-to-Gross HCRIS66.2%
Distress Probability ML48.3%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
39
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 14.6% places it above the state median. Among 39 size-comparable peers (32-130 beds), the median margin is -4.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (32-130), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)AR65$28.6M14.6%
ARKANSAS HEART HOSPITALAR112$205.9M1.2%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%
BHMC-CONWAYAR108$94.7M-15.6%
SALINE MEMORIAL HOSPITALAR130$91.4M-8.0%
NORTH ARKANSAS REGIONAL MEDICAAR120$89.1M-13.9%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ST VINCENT NORTHAR68$72.1M-18.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$602K+210bp18mo
Cost to Collect4.5%2.5%$573K+200bp12mo
Denial Rate Reduction12.0%6.5%$567K+198bp12mo
A/R Days Reduction5200.0%3800.0%$349K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$602K
Cost to Collect
$573K
Denial Rate Reduction
$567K
A/R Days Reduction
$349K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.1M
Current EBITDA$4.2M
+ RCM Uplift+$2.1M
Pro Forma EBITDA$6.3M
Current Margin14.6%
Pro Forma Margin22.0%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$6.5M$48.8M7.55x49.8%
Base (11x exit)10.0x11.0x$6.5M$55.7M8.63x53.9%
Bull Case9.0x11.0x$5.8M$64.8M11.15x62.0%
Bull (12x exit)9.0x12.0x$5.8M$72.4M12.46x65.6%
Bear Case11.0x10.0x$7.1M$36.1M5.09x38.5%
Bear (11x exit)11.0x11.0x$7.1M$42.0M5.92x42.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 67.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 32-130 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-17.5% / P50=-4.7% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.